- Home
- BCAB vs SANW Comparison
BCAB vs SANW Comparison
Compare BCAB & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- SANW
- Stock Information
- Founded
- BCAB 2007
- SANW 1980
- Country
- BCAB United States
- SANW United States
- Employees
- BCAB N/A
- SANW N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- SANW Farming/Seeds/Milling
- Sector
- BCAB Health Care
- SANW Consumer Staples
- Exchange
- BCAB Nasdaq
- SANW Nasdaq
- Market Cap
- BCAB 22.3M
- SANW 18.8M
- IPO Year
- BCAB 2020
- SANW 2010
- Fundamental
- Price
- BCAB $0.41
- SANW $5.41
- Analyst Decision
- BCAB Buy
- SANW Strong Buy
- Analyst Count
- BCAB 2
- SANW 1
- Target Price
- BCAB $1.00
- SANW $25.00
- AVG Volume (30 Days)
- BCAB 421.1K
- SANW 8.4K
- Earning Date
- BCAB 05-06-2025
- SANW 05-15-2025
- Dividend Yield
- BCAB N/A
- SANW N/A
- EPS Growth
- BCAB N/A
- SANW N/A
- EPS
- BCAB N/A
- SANW N/A
- Revenue
- BCAB $11,000,000.00
- SANW $54,993,808.00
- Revenue This Year
- BCAB N/A
- SANW N/A
- Revenue Next Year
- BCAB N/A
- SANW $14.25
- P/E Ratio
- BCAB N/A
- SANW N/A
- Revenue Growth
- BCAB N/A
- SANW 6.91
- 52 Week Low
- BCAB $0.24
- SANW $2.10
- 52 Week High
- BCAB $2.53
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- BCAB 50.31
- SANW 48.93
- Support Level
- BCAB $0.37
- SANW $5.35
- Resistance Level
- BCAB $0.42
- SANW $5.99
- Average True Range (ATR)
- BCAB 0.04
- SANW 0.46
- MACD
- BCAB -0.01
- SANW 0.05
- Stochastic Oscillator
- BCAB 35.88
- SANW 54.62
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.